Your email has been successfully added to our mailing list.

×
-0.000425079702444275 -0.000850159404888398 0 0.000425079702444124 -0.000637619553666336 -0.00382571732199787 -0.00510095642933054 -0.00319022316684382
Stock impact report

Sanofi to present key data on MS candidate April 23 [Seeking Alpha]

Sanofi - American Depositary Shares (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
Company Research Source: Seeking Alpha
Sanofi (NASDAQ:SNYscientific sessionPhase 2b clinical trialOn February 6, the companyannouncedSAR442168, in-licensed from Principia Biopharma, is a small molecule, brain-penetrant Bruton's tyrosine kinase (BTK) inhibitor. The company says it is potentially the first disease-modifying therapy to address the source of MS damage in the brain.Shares up1% Show less Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SNY alerts
Opt-in for
SNY alerts

from News Quantified
Opt-in for
SNY alerts

from News Quantified